Taken together, our results demonstrated macrophages facilitate post-MI arrhythmias via gap junction and KCa3.1 activation, and KCa3.1 might be a promising therapeutic target against post-MI arrhythmias. The gene discussed is KCNN4; the disease is cardiac arrhythmia.